Trials / Unknown
UnknownNCT00451984
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Aalborg University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The response to vaccination for hepatitis is reduced in patients with HIV infection. The hypothesis of the study is that adjuvant interleukin-2 administered subcutaneously at the time of vaccination improves the response rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Twinrix | |
| BIOLOGICAL | interleukin-2 |
Timeline
- Start date
- 2007-03-01
- First posted
- 2007-03-26
- Last updated
- 2007-11-01
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00451984. Inclusion in this directory is not an endorsement.